SCHEMBL22137443

SCHEMBL22137443

Cc1cc2c(cn1)N(C)C(=O)c1ccccc1N2C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK7 Q13164 6/20 0.55
▸ BRD4 O60885 3/20 0.55
▸ TTR P02766 3/20 0.49
▸ CES1 P23141 1/20 0.49
▸ DRD2 P14416 2/20 0.44
▸ HTR6 P50406 2/20 0.44
▸ PIK3CD O00329 3/20 0.43
▸ AURKA O14965 3/20 0.43
▸ PIK3C2G O75747 3/20 0.43
▸ PIK3CG P48736 3/20 0.43
▸ AURKB Q96GD4 3/20 0.43
▸ DCLK1 O15075 3/20 0.43
▸ LRRK2 Q5S007 3/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ MAPT P10636 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17059804 0.84 MAPK7 (0.54) MAPK7BRD4TTRCES1DRD2
SCHEMBL18379111 0.84 MAPK7 (0.54) MAPK7BRD4TTRCES1DRD2
SCHEMBL19496075 0.84 APP (0.41) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL12059596 0.78 TTR (0.69) TTRCES1DRD2HTR6LRRK2
SCHEMBL18369886 0.78 MAPK7 (0.57) MAPK7BRD4TTRCES1PIK3CD
SCHEMBL16127516 0.78 TTR (0.75) TTRCES1DRD2HTR6LRRK2
SCHEMBL18369884 0.75 MAPK7 (0.54) MAPK7BRD4TTRCES1PIK3CD
SCHEMBL18369826 0.75 MAPK7 (0.54) MAPK7BRD4PIK3CDAURKAPIK3C2G
SCHEMBL17721092 0.75 MAPK7 (0.57) MAPK7BRD4TTRCES1PIK3CD
SCHEMBL18369848 0.74 MAPK7 (0.53) MAPK7BRD4TTRCES1PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3738964-A1 PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS Dana Farber Cancer Institute, Inc. (US) 2020-11-18 — — EP disclosed
EP-3670515-A1 PYRIMIDO-DIAZEPINONE COMPOUNDS AND METHODS OF TREATING DISORDERS Dana Farber Cancer Institute, Inc. (US) 2020-06-24 — — EP disclosed
Send feedback